Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2024-03-19 00:00:00 ET · period of report 2024-03-15 · accession 0001048477-24-000036 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-19 | 2024-03-15 | BMRN | Ajer Jeffrey Robert | EVP, Chief Commercial Off | F - Tax | $83.87 | -22.6K | 71.5K | -24% | -$1.89M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-15 | F | D | 22,580 | $83.87 | 71,467 | D | — | — |